JMJD6 Is a Druggable Oxygenase That Regulates AR-V7 Expression in Prostate Cancer

Abstract
This study identifies JMJD6 as being critical for the generation of AR-V7 in prostate cancer, where it may serve as a tractable target for therapeutic intervention.
Funding Information
  • cDNA (pcDNA3-JMJD6-WT, pcDNA3-JMJD6-ASM2, pcDNA3-JMJD6-BM1)
  • Cancer Research UK (RIA17-ST2-014)
  • European Research Council (683136)
  • Swiss Cancer (4267)
  • Swiss National Science Foundation (176045)
  • Prostate Cancer Foundation (19CHAL08)
  • Italian Association for Cancer Research (22030)
  • CRUK (C8717/A18245)
  • Wellcome Trust (106244/Z/14/Z)
  • DOD (W81XWH-17-0323, W81XWH-20-0146, W81XWH-17-0414)
  • Prostate Cancer UK (CEO13_2-002)